Feb 15, 2018 — Accelerate Diagnostics, Inc. today announced preliminary full-year 2017 financial results including the quarter ending December 31, 2017. The company reported revenue for Q4 of $2.1 million, doubling revenue for the year, and signed agreements for 337 instruments. Contracts for customer evaluations covered 259 instruments while revenue placements totaled 78 across the U.S., European, and Middle East regions. Net […]
Jan 04, 2018 — Accelerate Diagnostics, Inc. announced today that Lawrence Mehren, President and Chief Executive Officer is scheduled to speak at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco. The presentation will take place Wednesday, January 10, 2018 at 10:30 AM, Pacific Time. See all press releases.
Dec 20, 2017 — Accelerate Diagnostics, Inc. is pleased to announce that the Accelerate Pheno™ system is the latest addition to the UAMS Clinical Microbiology Laboratory’s array of industry-redefining technologies for the treatment of infectious diseases.
Dec 06, 2017 — Accelerate Diagnostics, Inc. is pleased to announce that Peninsula Regional Medical Center (PRMC) has implemented the Accelerate Pheno™ system for patients. PRMC is the first hospital in Maryland to adopt this system, which was approved by the Food & Drug Administration earlier this year. PRMC said it made this investment in antimicrobial stewardship in the […]
Dec 06, 2017 — ICFO and Accelerate Diagnostics, S.L. have signed an agreement establishing a framework to explore scientific and technological fields of common interest. Through this agreement, Accelerate Diagnostics, S.L. will have access to state-of-the-art Biology Lab facilities and equipment housed within ICFO for, amongst other things, quality control testing of company products and employee training. Read the […]
Nov 27, 2017 — Accelerate Diagnostics, Inc. has teamed up with Sepsis Alliance for #GivingTuesday, November 28th, a global day of giving that harnesses the collective power of individuals, communities and organizations to encourage philanthropy and to celebrate generosity worldwide. Accelerate Diagnostics has pledged to match the first $10,000 gifted to Sepsis Alliance on #GivingTuesday to help raise awareness […]
Nov 16, 2017 — Dr. Watts has held a number of clinical and administrative leadership positions at two renowned academic medical centers, Northwestern (Feinberg School of Medicine, Northwestern Memorial Hospital) and the University of Michigan, and with his training and extensive clinical career as a Pulmonary-Critical Care specialist, he adds a comprehensive background of clinical practice and healthcare administration to […]
Nov 09, 2017 — Dr. Margie Morgan, Scientific Director Microbiology at Cedars-Sinai Medical Center, is scheduled to present on the impact that fast phenotypic antibiotic susceptibility results have to laboratory workflow and patient outcomes at the LabRoots Clinical Diagnostics and Research Virtual Event, November 9th at 12:30 p.m. ET.
Nov 02, 2017 — Accelerate Diagnostics, Inc. today announced preliminary financial results for the quarter ending September 30, 2017. The company further reported signed agreements for 295 instruments year to date; contracts for customer evaluations total 239 instruments while revenue generating placements grew to 56 across the U.S., European, and Middle East regions.
Oct 17, 2017 — Accelerate Diagnostics, Inc. will announce third quarter 2017 financial results at the close of U.S. financial markets on Thursday, November 2, 2017.